CityWizard t1_iyc9f2c wrote
Reply to comment by Predawnbread in Alzheimer’s Drug In Development, Lecanemab, May Benefit Some Patients But Carries Risks of Brain Swelling and Bleeding by Relevant_synapse
It's too risky, 28% is insignificant for the risk and cost of the drug. You're looking at a $20-30K USD/year and 17% chance for brain hemorrhage.
Katana_sized_banana t1_iydcbz3 wrote
New treatment are always expensive initially and get cheaper with time.
SerialStateLineXer t1_iydjqeg wrote
This will be likely be superseded by a better treatment before it goes off patent.
Viewing a single comment thread. View all comments